This story has been updated from a previous version.
NEW YORK, May 21 - InforMax said Monday it has signed a license agreement for its GenoMax enterprise software with the 16-campus University of North Carolina system.
Financial terms of the agreement were not disclosed. The deal was recorded in the company’s first-quarter earnings.
Richard Melzer, senior vice president of sales and marketing at InforMax, said the licensing agreement with UNC is the largest academic contract the company has signed, and the financial scope is “as large or larger than many of our commercial deals.”
“Genomics and bioinformatics have emerged as areas of strategic economic importance to North Carolina,” said Molly Corbett Broad, president of UNC, in a statement. “We are pleased that this licensing agreement will now provide students and faculty on all 16 UNC campuses with exposure and access to the world-class bioinformatics tools and data bases found in GenoMax.”
Corbett Broad said the license would foster interinstitutional research collaboration and technology transfer and strengthen related academic programs across the university. She added it would “help ensure a highly trained workforce for the state's growing biotechnology industry."
GenoMax will be installed at the UNC Chapel Hill Center for Bioinformatics, which is already hosting a GenoMax system on behalf of the Cystic Fibrosis Foundation, Melzer said.